Pure Global

XENTA HbA1c Rapid Quantitative Test - Indonesia BPOM Medical Device Registration

XENTA HbA1c Rapid Quantitative Test is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207420074. The device is manufactured by XENTA BIOMEDICAL SCIENCE CO., LTD from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. FOCUS DIAGNOSTIC INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
XENTA HbA1c Rapid Quantitative Test
Analysis ID: AKL 20207420074

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. FOCUS DIAGNOSTIC INDONESIA

AR Address

Jl. Jatipadang Raya No.9A, RT.6/RW.4, Kelurahan Jatipadang, Kecamatan Pasar Minggu, Kota Jakarta Selatan, DKI Jakarta 12540

Registration Date

Jun 07, 2024

Expiry Date

Aug 02, 2028

Product Type

Haematology Package and Kit

Glycosylated hemoglobin assay.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing